Autoimmune hemolytic anemia as an initial presentation in children with systemic lupus erythematosus: two case reports

J Int Med Res. 2022 Aug;50(8):3000605221115390. doi: 10.1177/03000605221115390.

Abstract

We report the cases of two children who presented with autoimmune hemolytic anemia (AIHA) as an initial presentation of systemic lupus erythematosus (SLE). Both patients had a positive Coombs test, anemia, and an increased number of spherocytes in their blood smear. The patient in Case 1 presented with fever, urticarial erythema, facial paresis, AIHA, and leucopenia. Immunological screening revealed low complement protein levels and positive anti-nuclear antibody, anti-double-stranded DNA, and antiphospholipid antibody results. A further laboratory workup revealed a positive lupus anticoagulant (LA) result and low factor II levels. She was diagnosed with lupus anticoagulant hypoprothrombinemia syndrome (LAHPS) in addition to SLE. The patient in Case 2 presented with fever, butterfly rash, thyroid enlargement, leucopenia, and AIHA. She was diagnosed with SLE with thyroiditis. Both patients were started on combined immunosuppressive therapy, and both patients' clinical symptoms finally resolved. A literature review on childhood SLE showed that AIHA is common in patients with SLE. LAHPS is an uncommonly identified cause of bleeding in patients with SLE, and it must be considered when evaluating children with a positive LA result.

Keywords: Autoimmune hemolytic anemia; antiphospholipid syndrome; children; factor II deficiency; lupus anticoagulant hypoprothrombinemia syndrome; systemic lupus erythematosus.

Publication types

  • Case Reports
  • Review

MeSH terms

  • Anemia, Hemolytic, Autoimmune* / complications
  • Anemia, Hemolytic, Autoimmune* / diagnosis
  • Antiphospholipid Syndrome*
  • Child
  • Female
  • Humans
  • Leukopenia* / etiology
  • Lupus Coagulation Inhibitor / therapeutic use
  • Lupus Erythematosus, Systemic* / complications
  • Lupus Erythematosus, Systemic* / diagnosis
  • Thrombocytopenia*

Substances

  • Lupus Coagulation Inhibitor